Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Chad, Winch"'
Autor:
David Roberge, Paul D. Brown, Anthony Whitton, Chris O'Callaghan, Anne Leis, Jeffrey Greenspoon, Grace Li Smith, Jennifer J. Hu, Alan Nichol, Chad Winch, Michael D. Chan
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
Stereotactic radiosurgery (SRS) has replaced whole brain radiotherapy (WBRT) as standard therapy for most patients with four or fewer brain metastases due to improved cognitive outcomes and more favorable health related quality of life (QoL). Whether
Externí odkaz:
https://doaj.org/article/0d1111aaddd5490cab3a1be9ded448f8
Autor:
Chad Winch, Ryo Nishikawa, Claire Phillips, Normand Laperriere, J. Gregory Cairncross, Wilson Roa, Alba A. Brandes, Christopher J. O'Callaghan, Seth Andrew Climans, Johan Menten, Wolfgang Wick, Michael Fay, James Perry, Warren P. Mason, Keyue Ding
Publikováno v:
Journal of Neuro-Oncology. 149:65-71
Tumor-related epilepsy may respond to chemotherapy. In a previously-published multi-centre randomized clinical trial of 562 elderly glioblastoma patients, temozolomide plus short-course radiotherapy conferred a survival benefit over radiotherapy alon
Autor:
Andrew J Song, Keyue Ding, Iyad Alnahhas, Normand J Laperriere, James Perry, Warren P Mason, Chad Winch, Chris J O’Callaghan, Johan J Menten, Alba A Brandes, Claire Phillips, Michael F Fay, Ryo Nishikawa, David Osoba, J Gregory Cairncross, Wilson Roa, Wolfgang Wick, Wenyin Shi
Publikováno v:
Neuro-Oncology Advances. 4
Autor:
Andrew J, Song, Keyue, Ding, Iyad, Alnahhas, Normand J, Laperriere, James, Perry, Warren P, Mason, Chad, Winch, Chris J, O'Callaghan, Johan J, Menten, Alba A, Brandes, Claire, Phillips, Michael F, Fay, Ryo, Nishikawa, David, Osoba, J Gregory, Cairncross, Wilson, Roa, Wolfgang, Wick, Wenyin, Shi
Publikováno v:
Neuro-oncology Advances
Background Lymphopenia may lead to worse outcomes for glioblastoma patients. This study is a secondary analysis of the CCTG CE.6 trial evaluating the impact of chemotherapy and radiation on lymphopenia, and effects of lymphopenia on overall survival
Autor:
Seth A, Climans, Alba A, Brandes, J Gregory, Cairncross, Keyue, Ding, Michael, Fay, Normand, Laperriere, Johan, Menten, Ryo, Nishikawa, Christopher J, O'Callaghan, James R, Perry, Claire, Phillips, Wilson, Roa, Wolfgang, Wick, Chad, Winch, Warren P, Mason
Publikováno v:
Journal of neuro-oncology. 149(1)
Tumor-related epilepsy may respond to chemotherapy. In a previously-published multi-centre randomized clinical trial of 562 elderly glioblastoma patients, temozolomide plus short-course radiotherapy conferred a survival benefit over radiotherapy alon
Autor:
Enrico Franceschi, J. Gregory Cairncross, Florence Laigle-Donadey, Christopher J. O'Callaghan, Keyue Ding, Wilson Roa, Olivier Chinot, James Perry, Michael Tills, John P. Rossiter, Warren P. Mason, Johan Menten, Michael Fay, Alba A. Brandes, Wolfgang Wick, Vassilis Golfinopoulos, Ryo Nishikawa, H Hirte, Claire Phillips, Normand Laperriere, Antje Wick, David Osoba, Brigitta G. Baumert, Chad Winch, Michael Back, L. Fariselli, Arjun Sahgal, Loïc Feuvret
Publikováno v:
New England Journal of Medicine, 376(11), 1027-1037. MASSACHUSETTS MEDICAL SOCIETY
BACKGROUND Glioblastoma is associated with a poor prognosis in the elderly. Survival has been shown to increase among patients 70 years of age or younger when temozolomide chemotherapy is added to standard radiotherapy (60 Gy over a period of 6 weeks
Autor:
Gregory Cairncross, Wolfgang Wick, Keyue Ding, Johan Menten, Wenyin Shi, Chad Winch, Warren P. Mason, James Perry, Normand Laperriere, Andrew Song, Alba A. Brandes, Ryo Nishikawa, Michael Fay, David Osoba, Christopher J. O'Callaghan, Wilson Roa, Claire Phillips
Publikováno v:
Journal of Clinical Oncology. 38:2547-2547
2547 Background: Lymphopenia (LMP) may lead to worse outcomes for patients with glioblastoma (GBM). This study is a secondary analysis of the CCTG CE.6 trial evaluating the impact of chemotherapy and radiation on LMP, as well as the association of LM
Autor:
James Perry, Warren P. Mason, Michael Fay, Normand Laperriere, Claire Phillips, J. Gregory Cairncross, Johan Menten, Christopher J. O'Callaghan, Alba Ariela Brandes, Wilson Roa, Ryo Nishikawa, Chad Winch, Keyue Ding
BACKGROUND: The EORTC (26981-22981)/NCIC CTG (CE.3) RCT in newly diagnosed GBM showed increased survival with concomitant and adjuvant temozolomide (TMZ) added to radiotherapy (RT). Study pts were 18-71 (median 56) years; however a sub-group analysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2874d9e81ae9384fa4f31e6c49fc22c6
https://europepmc.org/articles/PMC4144629/
https://europepmc.org/articles/PMC4144629/
Autor:
Matthew C. Cheung, Michael Crump, John Kuruvilla, Sudeep Shivakumar, Bingshu E. Chen, David Spaner, Rena Buckstein, Tanya Skamene, Kevin Imrie, Eugenia Piliotis, Diego Villa, Lois E. Shepherd, Kerry J. Savage, Stephen Couban, David MacDonald, Annette E. Hay, Tony Reiman, Chad Winch
Publikováno v:
Blood. 128:4162-4162
Background: The outcome of peripheral T-cell lymphomas (PTCLs) remains poor and improved therapies are needed. Retrospective data suggest that integration of anthracyclines in the primary therapy may not impact outcome, providing the rationale to exp
Autor:
Wendy R. Parulekar, Deborah K. Armstrong, Amanda Feeney, Dongsheng Tu, Johanne I Weberpals, Chad Winch, Geoff Hall, S. Lau, Philippe Gauthier, Diane Provencher, Helen Mackay, Paul Bessette, Elizabeth Eisenhauer, Ignacio A. Romero, Jonathan A. Ledermann, Charlie Gourley, Marcia Hall, Michael Fung-Kee-Fung, Christopher J. Gallagher
Publikováno v:
Journal of Clinical Oncology. 34:LBA5503-LBA5503
LBA5503 Background: The aim of this 2 stage randomized trial was to evaluate whether women undergoing neoadjuvant IV chemotherapy followed by delayed debulking surgery benefit from the addition of IP/IV treatment after surgery. Methods: Stage 1 was a